One Case of Severe Anaphylaxis Shock Induced by Tranexamic Acid Injection

Abstract

CLC Number:

R994.11

WANG Yiting, LI Weiwei, XIE Jingwen, GAO Min, LI Xiaoyan. One Case of Severe Anaphylaxis Shock Induced by Tranexamic Acid Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(8): 501-502.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2018/V15/I8/501

[1] 李博,高蕊,李睿,等. 药物临床试验不良反应/不良事件关联性判定方法研究探讨[J]. 中国新药杂志, 2014,23(12):1465-1470.
[2] Berry L L, Segal R, Sherrin T P, et al.Sensitivity and specificity of three methods of detecting adverse drug reactions[J]. Am J Hosp Pharm, 1988, 45(7):1534-1539.
[3] 魏晶,王瑜歆. 药品不良反应报告因果关系评价方法概述[J]. 中国药物警戒, 2011, 08(10):600-603.
[4] 杨华, 魏晶, 王嘉仡,等. 药品不良反应/事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10):581-584.
[5] Dunn C J, Goa K L.Tranexamic acid: a review of its use in surgery and other indications.[J]. Drugs, 1999, 57(6):1005-1032.
[6] Lucaspolomeni M M, Delaval Y, Menestret P, et al.A case of anaphylactic shock with tranexamique acid (Exacyl)[J]. Annales Francaises Danesthesie Et De Reanimation, 2004, 23(6):607-609.
[7] 张强. 氨甲环酸致过敏反应2例[J]. 中国药师, 2004, 7(8):598-598.
[8] 魏雪梅, 张晋萍. 氨甲环酸注射液致严重过敏反应[J]. 药物不良反应杂志, 2005, 7(2):145-145.
[9] 王金明. 氨甲环酸注射液的不良反应[J]. 江西医药, 2007, 42(3):273-274.
[10] 马玉莲. 氨甲环酸引起过敏性休克一例报告[J]. 青海医药杂志, 2010, 40(7):78-78.
[11] 金秋芳. 氨甲环酸致严重过敏反应1例报告[J]. 实用医院临床杂志, 2010, 07(6):146-146.
[12] 黄荣富, 苏静, 胡忠杰. 氨甲环酸致过敏性休克1例[J]. 中国医院药学杂志, 2011,31(4):344-344.
[13] 串俊兰, 吕晶, 韩勇. 氨甲环酸致不良反应个例报道文献分析[J]. 中国药师, 2013, 16(3):456-458.
[14] 刘产明, 朱月琴, 曾晓辉. 氨甲环酸氯化钠注射液引起过敏性休克的系统评价[C]//江苏省药学大会暨江苏省药师周. 2011.
[15] Imbesi S, Nettis E, Minciullo P L, et al.Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions[J]. Phar World Sci, 2010, 32(4):416-419.
[16] Calapai G.Systematic Review of Tranexamic Acid Adverse Reactions[J]. J Pharmacovigilance, 2015,3(4):171-177.
[17] 王道祥, 江腊梅, 王京娥,等. 86例药源性过敏性休克不良反应分析[J]. 中国药物警戒, 2010, 7(5):303-305.
[18] 刘仕娟. 滴速控制在减轻氨甲环酸氯化钠注射液不良反应中的应用[J]. 临床合理用药杂志, 2011, 4(30):61-62.

One Case of Severe Anaphylaxis Shock Induced by Tranexamic Acid Injection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.